Ovarian Mucinous Tumor — Trials

Ovarian Mucinous Tumor — Trials · CancerIndex

Clinical trials

Registered studies

46 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02364713	MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer	terminated	Phase 2	17	Mayo ClinicOTHER	1	Dec 11, 2025	clinicaltrials
NCT02923739	Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	terminated	Phase 2	9	M.D. Anderson Cancer CenterOTHER	1	Mar 13, 2024	clinicaltrials
NCT03641287	The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors	terminated	N/A	64	University of WashingtonOTHER	1	Nov 29, 2023	clinicaltrials
NCT00899093	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy

Data updated 22 days agoSource updated Dec 11, 2025source: clinicaltrials